Studies in cultured human cells have demonstrated that FXN overexpression also leads to oxidative stress and toxicity, in a similar way to frataxin deficiency, underscoring the importance of physiological levels of FXN to confer a therapeutic effect [101]. This evidence concerns the gene FXN and hyperinsulinemic hypoglycemia, familial, 4.